AHS will continue procedures at the COMPUDATA facility in Ravenna, Ohio, which is situated near Akron and 40 miles from Cleveland. Leading academic organizations, hospitals and cancer centers are adopting the MLC technology and seeing its benefits in considerably reduced treatment moments for a wider range of tumor types. These results showed the device was: Very reliable Highly accurate Mechanically stable Research continue steadily to validate CyberKnife System's unparalleled tumor targeting capabilities. Highlights consist of: Two dosimetric studies highlight the CyberKnife System's accuracy. A study undertaken at UT Southwestern Medical Center compared the CyberKnife Program and linac IMRT plans of sufferers with early-stage larynx malignancy. (more…)